In AML, miR-100-5p inhibits apoptosis by targeting ATM, arrests the differentiation of human granulocytes and monocytes, and promotes cell survival by targeting RBSP3 (Sun et al., 2020; Zheng et al., 2012). The gene discussed is CTDSPL; the disease is acute myeloid leukemia.